FIELD: biochemistry.
SUBSTANCE: invention relates to an antibody that binds to BCMA. Also a host cell producing the said antibody; nucleic acid encoding the said antibody are disclosed. Methods of producing the said antibody are disclosed.
EFFECT: invention has the ability to effectively treat diseases associated with latent myostatin.
11 cl, 30 ex, 30 tbl, 27 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODIES TO MYOSTATIN, POLYPEPTIDES CONTAINING FC-REGION VARIANTS, AND THEIR APPLICATION METHODS | 2016 |
|
RU2789884C2 |
| ANTIBODIES TO MYOSTATIN AND THEIR APPLICATION METHODS | 2017 |
|
RU2778945C2 |
| ANTIBODIES TO DENGUE VIRUS, POLYPEPTIDES CONTAINING FC-REGION OPTIONS AND THEIR APPLICATION METHODS | 2017 |
|
RU2758596C2 |
| CD40L ANTIBODIES AND METHODS OF TREATING CD40L RELATED DISEASES AND DISORDERS | 2016 |
|
RU2727646C2 |
| BISPECIFIC 2+1 ANTIBODIES | 2018 |
|
RU2797305C2 |
| METHOD OF PRODUCING A POLYPEPTIDE HETEROMULTITERS | 2014 |
|
RU2730594C2 |
| METHOD FOR PRODUCING A POLYPEPTIDE HETEROMULTIMER | 2014 |
|
RU2758952C1 |
| POLYPEPTIDE VARIANT THAT HAS PRESERVED OR DECREASED BINDING ACTIVITY TO FcγRIIa, PHARMACEUTICAL COMPOSITION CONTAINING IT AND THEIR APPLICATION | 2012 |
|
RU2749357C2 |
| VERSIONS OF FCΓRIIB-SPECIFIC FC-REGION | 2013 |
|
RU2729831C2 |
| BISPECIFIC ANTIBODY AGAINST RABIES VIRUS AND ITS APPLICATION | 2019 |
|
RU2764740C1 |
